Intelligent Bio Solutions (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25

✎ Contributed by Ty Griffin

The company’s non-invasive fingerprint drug screening system uses fingerprint sweat to screen for drugs such as cannabis, cocaine, methamphetamine, and opiates.
Results are available in under ten minutes, supporting faster, on-site decision-making in treatment and justice settings.
INBS is pursuing FDA approval and further entry into the U.S. market, where it currently operates in a Forensic Use Only capacity.
The company has over 450 active accounts in 24 countries, targeting sectors such as healthcare, justice, and workplace safety.
INBS partnered with SMARTOX, a U.S. distributor, to connect with stakeholders in criminal justice and addiction recovery.

Intelligent Bio Solutions (NASDAQ: INBS), a medical technology company specializing in rapid, non-invasive testing solutions, recently attended the RISE25 conference to demonstrate its portable Intelligent Fingerprint Drug Screening System, continuing its push into the U.S. market for rapid, non-invasive screening technologies (https://ibn.fm/1JSTS).

The event, held May 28–31 in Florida, attracted over 7,000 professionals from the fields of addiction treatment, mental health, and criminal justice. The conference has become a national gathering point for…